• Publications
  • Influence
Trends in infant bed sharing in the United States, 1993-2000: the National Infant Sleep Position study.
BACKGROUND Bed sharing with parents has been described as both beneficial to infant well-being and as a potentially lethal situation. OBJECTIVE To examine trends in bed sharing between infants andExpand
  • 190
  • 22
  • PDF
FDA drug approval summary: lapatinib in combination with capecitabine for previously treated metastatic breast cancer that overexpresses HER-2.
On March 13, 2007, the U.S. Food and Drug Administration approved lapatinib (Tykerb tablets; GlaxoSmithKline, Philadelphia), an oral, small molecule, dual tyrosine kinase inhibitor of ErbB-2 andExpand
  • 178
  • 8
Bortezomib for the Treatment of Mantle Cell Lymphoma
Purpose: To describe the Food and Drug Administration review and marketing approval considerations for bortezomib (Velcade) for the treatment of patients with mantle cell lymphoma. ExperimentalExpand
  • 201
  • 7
  • PDF
Low serum micronutrient concentrations predict frailty among older women living in the community.
BACKGROUND Micronutrient deficiencies are common among older adults. We hypothesized that low serum micronutrient concentrations were predictive of frailty among older disabled women living in theExpand
  • 176
  • 6
Vision, hearing, balance, and sensory impairment in Americans aged 70 years and over: United States, 1999-2006.
KEY FINDINGS Sensory impairments are a substantial problem for older Americans: One out of six has impaired vision; one out of four has impaired hearing; one out of four has loss of feeling in theExpand
  • 93
  • 6
  • PDF
FDA Approval: Blinatumomab
On December 3, 2014, the FDA granted accelerated approval of blinatumomab (Blincyto; Amgen, Inc.) for treatment of Philadelphia chromosome–negative relapsed or refractory precursor B-cell acuteExpand
  • 125
  • 6
Racial disparities in stillbirth risk across gestation in the United States.
OBJECTIVE We sought to determine factors associated with racial disparities in stillbirth risk. STUDY DESIGN Stillbirth hazard was analyzed using 5,138,122 singleton gestations from the NationalExpand
  • 72
  • 6
Term Pregnancy: A Period of Heterogeneous Risk for Infant Mortality
OBJECTIVE: To estimate the trend of maternal racial and ethnic differences in mortality for early-term (37 0/7 to 38 6/7 weeks of gestation) compared with full-term births (39 0/7 to 41 6/7 weeks ofExpand
  • 158
  • 5
Maternal age and the risk of stillbirth throughout pregnancy in the United States.
OBJECTIVE The objective of the study was to examine the relationship of maternal age with stillbirth risk throughout gestation. STUDY DESIGN A total of 5,458,735 singleton gestations withoutExpand
  • 235
  • 3
  • PDF
FDA Approval: Gemtuzumab Ozogamicin for the Treatment of Adults with Newly Diagnosed CD33-Positive Acute Myeloid Leukemia
On September 1, 2017, the FDA granted approval for gemtuzumab ozogamicin (Mylotarg; Pfizer Inc.) in combination with daunorubicin and cytarabine and as a monotherapy for the treatment of adultExpand
  • 65
  • 3